Skip to main content

The Amyloidosis Foundation

Clarkston, Michigan·EIN 20-0291856·NTEE H25 · Medical Research·501(c)(3)·Filing year 2023

The Amyloidosis Foundation's highest-paid officer, the President/ceo, was reported at $62,030 for 2023 (IRS Form 990), including base pay and other compensation. Reported CEO pay ranged from $56,160 to $62,030 between 2021 and 2023.

Total revenue
$535k
Total assets
$1.1M
Total expenses
$569k
Reported officers
8

How The Amyloidosis Foundation’s pay compares

Compared with Medical Research organizations of similar size in the East North Central states.

There were too few similar organizations to compare with, so this group goes beyond Michigan.

In line with peers

Most of the roles The Amyloidosis Foundation reports are paid within the middle half of what these Medical Research organizations pay for the same roles.

Show how each role compares

From the officer pay The Amyloidosis Foundation reported on its latest IRS Form 990.

THE ORGANIZATIONS MISSION IS TO INCREASE EDUCATION AND AWARENESS OF AMYLOIDOSIS, TO ASSIST PATIENTS IN FINDING QUALIFIED MEDICAL CARE AND TO SUPPORT RESEARCH.

Executive compensation

Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2023

Percentile bands compare each position's total pay with the same role at Medical Research organizations of similar size in the East North Central states. There were too few similar organizations to compare with, so this group goes beyond Michigan.

President/ceo
25th percentile to median
$62k

Plus 7 unpaid individuals.

Browse compensation in Medical Research →

Top pay as a share of expenses

In 2023, the highest total compensation at The Amyloidosis Foundation equaled 11% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2023)
11%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,115 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Up 10%
from 2021

From $56k in 2021 to $62k in 2023.

$56k
2021
$62k
2023
Pay for the position

Chief Executive Officer pay rose 10% from 2021 to 2023, while revenue fell 31%.

$56k in 2021 to $62k in 2023.

Pay for the position itself, not any one person. The officeholder may have changed between 2021 and 2023.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Common questions about The Amyloidosis Foundation

What does the Chief Executive Officer of The Amyloidosis Foundation earn?

In 2023, the Chief Executive Officer of The Amyloidosis Foundation received $62,030 in total compensation. This pay is below the median (the midpoint) for Chief Executive Officer roles among Medical Research organizations of similar size in the East North Central states, but above the bottom quarter of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at The Amyloidosis Foundation compare with similar nonprofits?

Compared with the same role at Medical Research organizations of similar size in the East North Central states, the 2023 pay of the Chief Executive Officer at The Amyloidosis Foundation falls between the 25th percentile and the median. In 2023, the highest total compensation at The Amyloidosis Foundation equaled 11% of the organization's total expenses. The median for medical research organizations is 10%.

What are The Amyloidosis Foundation's revenue and expenses?

In 2023, The Amyloidosis Foundation reported $535k in total revenue and $569k in total expenses on its IRS Form 990.